Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V

Clinical trial NCT05268289 · RECRUITING

Trial details

NCT number: NCT05268289
Sponsor: Novartis Pharmaceuticals
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Lupus Nephritis

Start date: 2022-08-10
Primary completion: 2026-03-19
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.